In a conference call on March 30th, Fathom's President and CEO, Marco Fregenal, outlined the company's progress in Q4 2025 ...

In a pivotal year for INmune Bio, the company has made significant strides in advancing its therapeutic platforms, yielding ...

On the heels of its fourth quarter 2025 earnings release, Spruce Power demonstrated a remarkable turnaround, delivering ...

HireQuest, Inc., a leading staffing industry player, has navigated a challenging macro environment to deliver solid ...

Phreesia, a leading healthcare technology company, recently concluded its fourth quarter and fiscal year 2026 earnings ...

Sangamo Therapeutics, a company at the forefront of gene therapy and genomic medicine development, has made significant ...

In a bid to navigate through turbulent market conditions, CVD Equipment Corporation has embarked on a comprehensive ...

CBAK Energy Technology has reported a dramatic surge in revenue for the fourth quarter of 2025, with consolidated net revenue increasing by 131.80% year over year to $58.80 million. The company's ...

In a groundbreaking fourth quarter earnings call, Bicara Therapeutics unveiled an array of remarkable achievements that ...

BitGo, the leading digital asset infrastructure company, has made significant strides in its fourth quarter and full year 2025 earnings, solidifying its position as a trusted partner for institutional ...

In a major milestone, Alpha Cognition has reported continued sales growth and ongoing demand expansion of its flagship product, ZUNVEYL, which is the first new oral Alzheimer's treatment approved in ...

Neumora Therapeutics has just concluded its fourth quarter and full year 2025 financial results conference call, and the company's prospects look brighter than ever. With a diverse pipeline of novel ...